Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Bioorg Med Chem ; 20(13): 4149-54, 2012 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-22633120

RESUMEN

Structurally modified phthalimide derivatives were prepared through condensation of phthalic and tetrafluorophthalic anhydride with selected sulfonamides with variable yields. All compounds were screened for their antimycobacterium activity against Mycobacterium tuberculosis H37Ra (ATCC 25177) using a micro broth dilution technique. The fluorinated derivatives (compounds 2c, 2d, 2f and 2h) had antimycobacterium activity comparable with classical sulfonamide drugs. The minimum inhibitory concentration (MIC) of compounds 2c, 2d, 2f and 2h was greater than that of isoniazid (MIC<0.02 µg/mL) and in vitro activity was greater than that of pyrazinamide, another first line antimycobacterium drug (MIC 50-100 µg/mL). The new compounds could be considered new lead compounds in the treatment of multi-drug resistant tuberculosis.


Asunto(s)
Antituberculosos/síntesis química , Ftalimidas/química , Animales , Antituberculosos/farmacología , Antituberculosos/toxicidad , Línea Celular , Supervivencia Celular/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Isoniazida/farmacología , Ratones , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/efectos de los fármacos , Ftalimidas/farmacología , Ftalimidas/toxicidad , Pirazinamida/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA